Skip to main content

Table 5 Multiple logistic regression analysis for LCT

From: HPV-specific risk assessment of cervical cytological abnormalities

Genotypes

P

OR (for LCT (+))

95%CI

HPV-16

< 0.001

4.591

3.17–6.66

HPV-18

0.036

2.021

1.05–3.90

HPV-33

0.001

3.165

1.61–6.22

HPV-39

0.002

2.841

1.47–5.50

HPV-45

0.025

13.775

1.40–135.92

HPV-51

0.002

4.765

1.80–12.63

HPV-52

< 0.001

3.623

2.54–5.17

HPV-53

< 0.001

3.796

2.20–6.54

HPV-56

0.001

5.747

2.13–15.52

HPV-58

< 0.001

5.034

3.27–7.76

HPV-59

0.001

5.838

2.11–16.13

HPV-66

< 0.001

6.001

2.55–14.14

HPV-68

0.027

2.299

1.10–4.80

HPV-11

0.009

3.21

1.34–7.70

HPV-42

0.039

11.811

1.14–122.64

cp8304

< 0.001

2.984

1.62–5.51

age

 21–30

0.001

1

 

 31–40

0.015

1.727

1.11–2.69

 41–50

0.736

1.076

0.70–1.65

  > 50

0.915

0.975

0.62–1.54

  1. LCT (+) Positive LCT results
  2. OR Odds ratio